Literature DB >> 29388238

Argon attenuates multiorgan failure following experimental aortic cross-clamping.

Guillaume Savary1,2,3, Fanny Lidouren1, Jérôme Rambaud1,2,3, Matthias Kohlhauer1,2,3, Thierry Hauet4,5, Patrick Bruneval6, Bruno Costes7, Alain Cariou8, Bijan Ghaleh1,2,3, Nicolas Mongardon1,2,3,9, Renaud Tissier1,2,3.   

Abstract

AIMS: Argon has been shown to prevent ischaemic injuries in several scenarios of regional ischaemia. We determined whether it could provide a systemic effect in a model of multiorgan failure (MOF) induced by aortic cross-clamping.
METHODS: Anaesthetized rabbits were submitted to aortic cross-clamping (30 min) and subsequent reperfusion (300 min). They were either ventilated with oxygen-enriched air throughout the protocol [fraction of inspired oxygen (FiO2 ) = 30%; control group) or with a mixture of 30% oxygen and 70% argon (argon groups). In a first group treated with argon ('Argon-Total'), its administration was started 30 min before ischaemia and maintained throughout the protocol. In the two other groups, the administration was started either 30 min before ischaemia ('Argon-Pre') or at the onset of reperfusion ('Argon-Post'), for a total duration of 2 h. Cardiovascular, renal and inflammatory endpoints were assessed throughout protocol.
RESULTS: Compared with control, shock was significantly attenuated in Argon-Total and Argon-Pre but not Argon-Post groups (e.g. cardiac output = 62±5 vs. 29 ± 5 ml min-1 kg-1 in Argon-Total and control groups at the end of the follow-up). Shock and renal failure were reduced in all argon vs. control groups. Histopathological examination of the gut showed attenuation of ischaemic lesions in all argon vs. control groups. Blood transcription levels of interleukin (IL) 1β, IL-8, IL-10 and hypoxia-inducible factor 1α were not significantly different between groups.
CONCLUSION: Argon attenuated clinical and biological modifications of cardiovascular, renal and intestinal systems, but not the inflammatory response, after aortic cross-clamping. The window of administration was crucial to optimize organ protection.
© 2018 The British Pharmacological Society.

Entities:  

Keywords:  acute kidney injury (nephrology); animal models (drug development); critical care; intensive care (critical care)

Mesh:

Substances:

Year:  2018        PMID: 29388238      PMCID: PMC5980505          DOI: 10.1111/bcp.13535

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  27 in total

1.  Beneficial Properties of Argon After Experimental Subarachnoid Hemorrhage: Early Treatment Reduces Mortality and Influences Hippocampal Protein Expression.

Authors:  Anke Höllig; Agnieszka Weinandy; Jingjin Liu; Hans Clusmann; Rolf Rossaint; Mark Coburn
Journal:  Crit Care Med       Date:  2016-07       Impact factor: 7.598

2.  Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal.

Authors:  C J Chiu; A H McArdle; R Brown; H J Scott; F N Gurd
Journal:  Arch Surg       Date:  1970-10

3.  Dose dependent neuroprotection of the noble gas argon after cardiac arrest in rats is not mediated by K(ATP)-channel opening.

Authors:  Anne Brücken; Pinar Kurnaz; Christian Bleilevens; Matthias Derwall; Joachim Weis; Kay Nolte; Rolf Rossaint; Michael Fries
Journal:  Resuscitation       Date:  2014-02-28       Impact factor: 5.262

4.  Delayed argon administration provides robust protection against cardiac arrest-induced neurological damage.

Authors:  Anne Brücken; Pinar Kurnaz; Christian Bleilevens; Matthias Derwall; Joachim Weis; Kay Nolte; Rolf Rossaint; Michael Fries
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

5.  Argon Mediates Anti-Apoptotic Signaling and Neuroprotection via Inhibition of Toll-Like Receptor 2 and 4.

Authors:  Felix Ulbrich; Kai Kaufmann; Martin Roesslein; Franziska Wellner; Volker Auwärter; Jürgen Kempf; Torsten Loop; Hartmut Buerkle; Ulrich Goebel
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

6.  Neuroprotection by argon ventilation after perinatal asphyxia: a safety study in newborn piglets.

Authors:  Thomas Alderliesten; Laurent M A Favie; Robert W Neijzen; Volker Auwärter; Cora H A Nijboer; Roland E J Marges; Carin M A Rademaker; Jürgen Kempf; Frank van Bel; Floris Groenendaal
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

7.  Inhaled 45-50% argon augments hypothermic brain protection in a piglet model of perinatal asphyxia.

Authors:  Kevin D Broad; Igor Fierens; Bobbi Fleiss; Eridan Rocha-Ferreira; Mojgan Ezzati; Jane Hassell; Daniel Alonso-Alconada; Alan Bainbridge; Go Kawano; Daqing Ma; Ilias Tachtsidis; Pierre Gressens; Xavier Golay; Robert D Sanders; Nicola J Robertson
Journal:  Neurobiol Dis       Date:  2015-12-10       Impact factor: 5.996

8.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.

Authors:  Simon D Harding; Joanna L Sharman; Elena Faccenda; Chris Southan; Adam J Pawson; Sam Ireland; Alasdair J G Gray; Liam Bruce; Stephen P H Alexander; Stephen Anderton; Clare Bryant; Anthony P Davenport; Christian Doerig; Doriano Fabbro; Francesca Levi-Schaffer; Michael Spedding; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

9.  Heme Oxygenase-1 Mediates Neuroprotection Conferred by Argon in Combination with Hypothermia in Neonatal Hypoxia-Ischemia Brain Injury.

Authors:  Hailin Zhao; Sian Mitchell; Stefania Koumpa; Yushi Tracy Cui; Qingquan Lian; Henrik Hagberg; Mark R Johnson; Masao Takata; Daqing Ma
Journal:  Anesthesiology       Date:  2016-07       Impact factor: 7.892

10.  A randomized trial of the effects of the noble gases helium and argon on neuroprotection in a rodent cardiac arrest model.

Authors:  Patrick Zuercher; Dirk Springe; Denis Grandgirard; Stephen L Leib; Marius Grossholz; Stephan Jakob; Jukka Takala; Matthias Haenggi
Journal:  BMC Neurol       Date:  2016-04-04       Impact factor: 2.474

View more
  4 in total

1.  The effects of whortleberry on ischemia reperfusion-induced myocardial injury in rats.

Authors:  Sedat Ozan Karakişi; Doğuş Hemşinli; Şaban Ergene; Tolga Mercantepe; Levent Tümkaya; Adnan Yılmaz
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-01-23       Impact factor: 0.332

2.  Tea Grape Reduces Abdominal Aortic Occlusion-Induced Lung Injury.

Authors:  Doğuş Hemşinli; Saban Ergene; Sedat Ozan Karakişi; Tolga Mercantepe; Levent Tumkaya; Adnan Yilmaz; Kerimali Akyilzdiz
Journal:  Braz J Cardiovasc Surg       Date:  2020-08-01

Review 3.  Update of the organoprotective properties of xenon and argon: from bench to beside.

Authors:  Roehl Anna; Rossaint Rolf; Coburn Mark
Journal:  Intensive Care Med Exp       Date:  2020-02-24

4.  The Role of Vaccinium Myrtillus in the Prevention of Renal Injury in an Experimental Model of Ruptured Abdominal Aortic Aneurysm.

Authors:  Şaban Ergene; Doğuş Hemşinli; Sedat Ozan Karakişi; Tolga Mercantepe; Levent Tumkaya; Adnan Yilmaz
Journal:  Braz J Cardiovasc Surg       Date:  2020-08-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.